KATHERINA CHAPPELL: Open Payments
NPI 1942692124 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 60 payments from 17 companies in 2025. Trend: 2023 $835 · 2024 $1,734 · 2025 $1,471
Food & beverage: $1,391Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $436 |
| GENZYME CORPORATION | 4 | $220 |
| Amgen Inc. | 5 | $119 |
| Janssen Biotech, Inc. | 3 | $118 |
| Novartis Pharmaceuticals Corporation | 3 | $94 |
| LEO Pharma Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| UCB, Inc. | 3 | $62 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $60 |
| Lilly USA, LLC | 2 | $37 |
Products named: SKYRIZI, RINVOQ, OTEZLA, TREMFYA, DUPIXENT, ADBRY, Sotyktu, COSENTYX.
Industry payments across NV — which companies pay providers there.
